Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
CrowdStrike A | CRWD | Oct 31, 2024 | 296.87 | -3.44 |
Crown Castle | CCI | Oct 31, 2024 | 107.49 | -0.30 |
Crown Crafts | CRWS | Oct 31, 2024 | 4.54 | -1.94 |
Crown ElectroKinetics | CRKN | Oct 31, 2024 | 0.96 | +8.24 |
Crown Holdings | CCK | Oct 31, 2024 | 93.55 | -2.23 |
Crown LNG | CGBS | Oct 31, 2024 | 0.27 | -6.27 |
Cryo-Cell International | CCEL | Oct 31, 2024 | 7.34 | +0.41 |
CryoPort | CYRX | Oct 31, 2024 | 6.66 | -2.20 |
CS Disco | LAW | Oct 31, 2024 | 5.88 | -1.18 |
CSG Systems International | CSGS | Oct 31, 2024 | 46.61 | -1.44 |
CSP | CSPI | Oct 31, 2024 | 12.47 | -0.40 |
CSW Industrials | CSWI | Oct 31, 2024 | 353.10 | -1.94 |
CSX | CSX | Oct 31, 2024 | 33.64 | +0.30 |
CTO Realty Growth | CTO | Oct 31, 2024 | 19.35 | -0.87 |
CTO Realty Growth A Pref | CTO-A | Oct 31, 2024 | 24.46 | +1.28 |
CTS | CTS | Oct 31, 2024 | 49.49 | -2.54 |
CubeSmart | CUBE | Oct 31, 2024 | 47.84 | -0.89 |
Cue Biopharma | CUE | Oct 31, 2024 | 1.61 | -8.00 |
Cullen Frost Bankers B Pref | CFR-B | Oct 31, 2024 | 20.31 | +1.04 |
Cullen/Frost Bankers | CFR | Oct 31, 2024 | 127.35 | -2.39 |
Cullinan Therapeutics | CGEM | Oct 31, 2024 | 15.55 | -4.13 |
Cullman Bancorp | CULL | Oct 31, 2024 | 9.71 | 0.00 |
Culp | CULP | Oct 31, 2024 | 5.31 | -2.03 |
Cumberland Pharmaceuticals | CPIX | Oct 31, 2024 | 1.12 | -5.88 |
Cummins | CMI | Oct 31, 2024 | 328.98 | -0.86 |
Cumulus Media A | CMLS | Oct 31, 2024 | 1.17 | 0.00 |
Curbline Properties Corp. When Issued | CURB | Oct 31, 2024 | 22.63 | 0.00 |
Curevac N.V. | CVAC | Oct 31, 2024 | 2.74 | -2.14 |
CuriosityStream | CURI | Oct 31, 2024 | 2.41 | -0.82 |
Curis | CRIS | Oct 31, 2024 | 4.28 | -4.46 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.